[4] A major double-blind study (17,604 participants) showed semaglutide (Wegovy) reduces major adverse cardiovascular events by 20% in adults with overweight/obesity and established cardiovascular disease, but without diabetes
Its clinical name is BPC-157 with the addition of tb500, and it has quickly become a go to option for individuals who want to optimize healing and resilience
Follicle Enlargement Studies confirm GHK-Cu increases the physical size of hair follicles a critical finding, because miniaturized follicles produce thin, weak "vellus" hairs rather than the thick "terminal" hairs that make up visible, healthy hair
GLP-1 medications speak the same language your body already uses after a meal, just louder and for longer
Gaucher C, Boudier A, Bonetti J, Clarot I, Leroy P, Parent M
Trials like FLOW (semaglutide) are actively investigating and further solidifying the role of GLP-1s in preserving kidney function in T2DM patients